Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Apotex Corp., priced at $0.8983 per EA under NDC 60505434706. Its NADAC has been published 117 times since Apr 3, 2024.
Strength
75 mg/1
Manufacturer
Apotex Corp.NDC
60505434706
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208070On Market Since
2/13/2024
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 117 times since Apr 3, 2024, and over the history we have for it it has declined 85.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8983 per EA |
|---|---|
| All-time high | $6.3586 (Apr 10, 2024) |
| All-time low | $0.8478 (Apr 22, 2026) |
| 52-week high | $1.4699 |
| 52-week low | $0.8478 |
| Median price | $1.6942 |
| Average price | $1.7038 |
| Largest weekly change | -58.2% (Apr 17, 2024) |
| Weeks tracked | 117 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the dabigatran etexilate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Apotex Corp., is $0.8983 per EA (NDC 60505434706), effective Jun 24, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 85.9%. It has been tracked across 117 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Apr 3, 2024, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8478 (Apr 22, 2026) to a high of $6.3586 (Apr 10, 2024), with a median of $1.6942 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DABIGATRAN ETEXILATE 75 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 60505434706) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification